Box score
Bonum Therapeutics, Inc.
Reported $26.9M sold in a new Form D filed April 17, 2026 (Seattle, Washington).
- Biggest raise
- $26.9M filed Apr 17, 2026
- League
- Bio & Health Biotechnology
- Based in
- Seattle, Washington
- Season rank
- #96 of 1,121 in the Bio & Health League; #820 of 10,745 overall (2026)
- Incorporated
- 2021
- Entity
- Corporation
Form D filings since 2024 1
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-04-17 | New notice | $26.9M | $32.3M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1898714.
Similar raises, 2026
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Zocalo Health Inc. | Bio & Health | $22.6M |
| 2 | CytoDyn Inc. | Bio & Health | $18.6M |
| 3 | Accipiter Biosciences Inc. | Bio & Health | $10.5M |
| 4 | Pluristyx Inc. rookie provisional | Bio & Health | $9.8M |
| 5 | Solius Labs, Inc. | Bio & Health | $3.5M |
| 6 | Aptevo Therapeutics Inc. | Bio & Health | $3.5M |